Regenerative Medicine at Organogenesis
The field of Regenerative Medicine is developing and coming into its own. As a pioneer in this field, Organogenesis is proud to have been at the forefront of this new era since its early days as an MIT-spin-off, all the way through making this technology into a reality for patients today.
A new era in medicine arrived when Organogenesis received one of the first FDA approvals for a living, human cell-based product. Apligraf® and Dermagraft® are now the leading regenerative medicine brands in the world.
The development of Organogenesis’ first technology platform (delivering living cells to the body via a 3-D construct) was one of the field's first major breakthroughs.